Cargando…
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics
Psoriasis is a common chronic inflammatory skin disease associated with several comorbidities and reduced quality of life. In the past decades, highly effective targeted therapies have led to breakthroughs in the management of psoriasis, providing important insights into the pathogenesis. This artic...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254604/ https://www.ncbi.nlm.nih.gov/pubmed/34235053 http://dx.doi.org/10.2147/PTT.S294173 |
_version_ | 1783717762399469568 |
---|---|
author | Ben Abdallah, Hakim Johansen, Claus Iversen, Lars |
author_facet | Ben Abdallah, Hakim Johansen, Claus Iversen, Lars |
author_sort | Ben Abdallah, Hakim |
collection | PubMed |
description | Psoriasis is a common chronic inflammatory skin disease associated with several comorbidities and reduced quality of life. In the past decades, highly effective targeted therapies have led to breakthroughs in the management of psoriasis, providing important insights into the pathogenesis. This article reviews the current concepts of the pathophysiological pathways and the recent progress in antipsoriatic therapeutics, highlighting key targets, signaling pathways and clinical effects in psoriasis. |
format | Online Article Text |
id | pubmed-8254604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82546042021-07-06 Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics Ben Abdallah, Hakim Johansen, Claus Iversen, Lars Psoriasis (Auckl) Review Psoriasis is a common chronic inflammatory skin disease associated with several comorbidities and reduced quality of life. In the past decades, highly effective targeted therapies have led to breakthroughs in the management of psoriasis, providing important insights into the pathogenesis. This article reviews the current concepts of the pathophysiological pathways and the recent progress in antipsoriatic therapeutics, highlighting key targets, signaling pathways and clinical effects in psoriasis. Dove 2021-06-29 /pmc/articles/PMC8254604/ /pubmed/34235053 http://dx.doi.org/10.2147/PTT.S294173 Text en © 2021 Ben Abdallah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Ben Abdallah, Hakim Johansen, Claus Iversen, Lars Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title | Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title_full | Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title_fullStr | Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title_full_unstemmed | Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title_short | Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics |
title_sort | key signaling pathways in psoriasis: recent insights from antipsoriatic therapeutics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254604/ https://www.ncbi.nlm.nih.gov/pubmed/34235053 http://dx.doi.org/10.2147/PTT.S294173 |
work_keys_str_mv | AT benabdallahhakim keysignalingpathwaysinpsoriasisrecentinsightsfromantipsoriatictherapeutics AT johansenclaus keysignalingpathwaysinpsoriasisrecentinsightsfromantipsoriatictherapeutics AT iversenlars keysignalingpathwaysinpsoriasisrecentinsightsfromantipsoriatictherapeutics |